McKesson and CD&R take Option Care private in $5.8B deal
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion transaction.
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion transaction.
GTCR acquired PE-backed Tactacam in a transaction valued at over $1 billion, marking a secondary buyout in the action camera segment.
Bain Capital Private Equity completed the acquisition of a 9.75% stake in baudroie, Inc. (TSE:4413) for ¥9.3 billion, signaling entry into the Japanese corporate ecosystem.
Singapore's VSMC announced a $7.8 billion semiconductor fabrication facility targeting volume production of 44,000 wafers per month by 2027, amid global fab expansion.
Activist investor Bruce Schanzer's Erez Asset Management disclosed a 5.8% stake in Empire State Realty Trust after acquiring the position for approximately $43 million.
IPO activity intensified globally with 20 new issues opening for subscription, though smart ring maker Oura postponed its $2.1 billion IPO citing market conditions.
Comparisons to SpaceX's post-IPO performance raise questions about whether AI-focused Anthropic could maintain trading stability upon public listing.